Agfa-gevaert Nv · EURONEXT:AGFB
Agfa-gevaert Nv — Q3 2013 Earnings Presentation
18 slides from Agfa-gevaert Nv's earnings presentation, Nov 13, 2013
Slide 1: Q3 2013 Results
Q3 2013 Results November 13, 2013
Slide 2: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q3'12 Q3'13 Δ% 9M'12 9M'13 Δ% (excl. X-rate) (excl. X-rate) Sales 766 689 -10.1%(-5.9%) 2,279 2,126 -6.7%(-4.6%) Gross Profit* 209 192 -8.1% 643 606 -5.8% as a % of sales 27.3% 27.9% 28.2% 28.5% SG&A* -140 -128 -8.6% -431 -405 -6.0% SG&A as % of sales 18.
Slide 3: Net Financial Debt (in million Euro)
Net Financial Debt (in million Euro) 661 569 500 445 434 391 398 313 339 337 299 267 291 306 295 291 261 161 189 09 09 09 09 10 10 10 11 11 11 11 12 12 12 12 13 13 13 0 21 1' 2' 3' 4' 1' 3' 4' 1' 2' 3' 4' 1' 2' 3' 4' 1' 2' 3' Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q 3
Slide 4: Working Capital: Key Figures (in million Euro/days)
Working Capital: Key Figures (in million Euro/days) 800 Inventories 800 Trade Receivables* 800 Trade Payables 700 717719 711 700 700 688 688 691 686 600 627 639 635 648 600 600 591 585 597 583 577 543 539 500 514 500 521532 527 500 483 482 496 476 487482 498484 469473471 467 438 452 452 400 400 436
Slide 5: Main Group Drivers behind Key Figures
Main Group Drivers behind Key Figures Q3 2013 • Group revenue impacted by strong currency effects, the product portfolio rationalization, the weak economic conditions and the decline of the analog businesses. • Gross margin continued to improve year-on-year. Part of the improvement is attributable t
Slide 6: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q3 '12** Q3 '13 Δ% 9M'12** 9M'13 Δ% Recurring EBIT* 29 26 -10.3% 82 83 1.2% Restructuring and non-recurring -2 -9 -23 13 Operating result 27 17 59 96 Non-operating result -19 -17 -63 -54 Profit before taxes 8 0 -4 42 Taxes -6 -6 -12 -37 Net result 2 -6 -1
Slide 7: Graphics
Graphics AGFA &
Slide 8: Graphics: Key Figures (in million Euro)
Graphics: Key Figures (in million Euro) Q3'12 Q3'13 Δ% 9M'12 9M'13 Δ% (excl. curr.) (excl. curr. ) Sales 417 365 -12.5%(-8.6%) 1,231 1,116 -9.3%(-7.4%) Gross Profit* 100 94 -6.0% 308 284 -7.8% as a % of sales 24.0% 25.8% 25.0% 25.4% SG&A* -76 -66 -13.2% -237 -214 -9.7% as % of sales 18.2% 18.1% 19.3
Slide 9: Graphics: Main Drivers behind Key Figures
Graphics: Main Drivers behind Key Figures Q3 2013 • Revenue impacted by adverse currency effects, the tough investment climate, the product portfolio rationalization and the decline in the analog CtF business, which was exceptionally strong in Q3 2012. • In CtP, plate volumes remained stable but the
Slide 10: Graphics: YTD Sales per Business Segment
Graphics: YTD Sales per Business Segment 9m 2013 100% = 1,116 million Euro Inkjet, Software, Service 18% Analog Prepress 16% Digital Prepress 66% 10
Slide 11: HealthCare
HealthCare AGFA &
Slide 12: HealthCare: Key Figures (in million Euro)
HealthCare: Key Figures (in million Euro) Q3'12 Q3'13 Δ% 9M'12 9M'13 Δ% (excl. curr.) (excl. curr. ) Sales 297 274 -7.7%(-2.6%) 875 844 -3.5%(-0.8%) Gross Profit* 104 92 -11.5% 313 291 -7.0% as a % of sales 35.0% 33.6% 35.8% 34.5% SG&A* -58 -56 -3.4% -175 -173 -1.1% as % of sales 19.5% 20.4% 20.0% 2
Slide 13: HealthCare: Main Drivers behind Key Figures
HealthCare: Main Drivers behind Key Figures Q3 2013 • On a currency comparable basis, the decline is fully attributable to a decline in the traditional X-ray film business, which was exceptionally strong in Q3 2012. • The digital radiography business performed well, mainly due to the strong growth i
Slide 14: HealthCare: YTD Sales per Business Segment
HealthCare: YTD Sales per Business Segment 9m 2013 100% = 844 million Euro Hardcopy 30% Classic Radiology 10% CR/Modalities 19% Imaging IT* HIS/CIS 28% 13% HealthCare IT = 41% * Includes Radiology and Cardiology IT 14
Slide 15: Specialty Products
Specialty Products AGFA &
Slide 16: Specialty Products: Key Figures (in million Euro)
Specialty Products: Key Figures (in million Euro) Q3'12 Q3'13 Δ% 9M'12 9M'13 Δ% (excl. curr.) (excl. curr. ) Sales 52 50 -3.8%(-1.5%) 173 166 -4.0%(-3.2%) Gross Profit* 5 6 20.0% 22 31 40.9% as a % of sales 9.6% 12.0% 12.7% 18.7% SG&A* -5 -5 0.0% -18 -17 -5.6% as % of sales 9.6% 10.0% 10.4% 10.2% R&
Slide 17: Specialty Products: Main Drivers behind Key Figures
Specialty Products: Main Drivers behind Key Figures Q3 2013 • The Synaps Synthetic Paper, Orgacon Electronic Materials, Security, printed circuit board and microfilm businesses performed well. • Recurring EBIT improved to minus 0.5 million Euro 17
Slide 18: Q&A
Q&A AGFA &